New Drugs: Oleogel-S10 for Epidermolysis Bullosa
Dr. Ted Rosen discusses the investigational drug oleogel-S10 for epidermolysis bullosa. Ted Rosen, MD, FAAD Professor of Dermatology, Baylor College of Medicine, Houston, Texas Oleogel-S10 (Filsuvez, Amryt) is under consideration by the FDA and approved in the European Union (EU) and Great Britain for the treatment of partial thickness wounds associated with junctional and dystrophic epidermolysis bullosa in […]
Understanding Herbal-based Therapies
Dr. Carl Thornfeldt discusses the science behind herbal-based therapies as well as the complexities of herbal therapy product development. Carl Thornfeldt, MD, CT Derm Pc, Fruitland, Idaho, and Owner Epionce and Thornfeldt and Associates Research “Herbal therapy is focused on the secondary metabolites—the primary bioactives in herbal extracts. They are in the plant to protect […]